Around 30 million adults in the US have obstructive sleep apnea (OSA) and about 80% of them are undiagnosed. That means millions of people are suffering and might not realize their snoring or chronic ...
ProSomnus announced today that it raised $38 million through a strategic investment from Catalio Capital Management.
Compare the efficacy, benefits, and drawbacks of CPAP therapy and tirzepatide (Zepbound), two of the best treatments for sleep apnea.